Back to EGX

Cleopatra Hospital Company stock price and financial data

Egypt · Health Care · Health Care Providers & Services · EGP

Invest with RicherFin and research the stock. Cleopatra Hospital Company (CLHO.CA), EGX : share price and history, results and fundamentals, analysis tools and peer companies.

Buy Cleopatra Hospital Company shares Sign up

An investment account is required to buy shares. Demo mode uses virtual money: no order is sent to the market.

Price history

Price as of 07 Oct 2026 15.35 EGP
Last change -0.97% 7D change +1.32%

Issuer profile

Cleopatra Hospital SAE is an Egypt-based healthcare facilities & services business in the healthcare sector, listed on the Egyptian Exchange under ticker CLHO.CA. Cleopatra Hospital SAE is an Egypt-based hospital, which provides health and medical services, as well as the medical care of inpatients. Cleopatra Hospital SAE holds stakes in four hospitals in the Greater Cairo Area: Cleopatra Hospital, Cairo Specialized Hospital, Nile Badrawi Hospital and Al Shorouk Hospital, offering a full array of general and emergency healthcare services. Cleopatra Hospital SAE's service offerings include general surgery, emergency and ambulance services, cardiology, gynecology and obstetrics, oncology, orthopedics and a number of outpatient clinics, including dental, physiotherapy and primary care. Cleopatra Hospital SAE's facilities allow to conduct routine examinations, simple procedures and operations, and general services such as pharmacy, blood bank and diagnostic services. Its investment profile is best assessed through product quality, regulatory compliance, distribution, pricing, and demand from Egypt’s healthcare market. Key analysis points include business model clarity, durability of revenue sources, cost control, cash conversion, leverage, shareholder structure, and the consistency of public disclosures over time.

Fundamentals

connect to view more

Sign in to unlock the full fundamentals history.

Sign in
Metric  (EGP, B) 2025 2024 2023 2022 2021
Revenue Total Revenue 7.31
EBITDA 1.93
EBIT 1.64
Net income Net Income 0.93
Net margin 12.73%